Koyfin Home > Directory > Health Care > Nymox Pharm Corp > Total Equity

Nymox Pharm Corp Total Equity Chart (NYMX)

Nymox Pharm Corp annual/quarterly Total Equity from 2010 to 2020.
  • Nymox Pharm Corp Total Equity for the quarter ending June 06, 2020 was $-1m a 631.02% decrease of -7m year over year
  • Nymox Pharm Corp Total Equity for the last 12 months ending June 06, 2020 was $-1m a 631.02% decrease of -7m year over year
  • Nymox Pharm Corp Annual Total Equity for 2019 was $3m a -103.07% decrease of -4m from 2018
  • Nymox Pharm Corp Annual Total Equity for 2018 was $7m a 117.87% increase of 8m from 2017
  • Nymox Pharm Corp Annual Total Equity for 2017 was $-1m a 80.74% decrease of -1m from 2016
Other Balance Sheet Metrics:
  • Nymox Pharm Corp Total Assets for the quarter ending September 09, 2018 was $5m a 79.51% increase of 4m year over year
  • Nymox Pharm Corp Other Liabilities for the quarter ending December 12, 2016 was $0m a 208,053.10% decrease of -2m year over year
View Chart On Koyfin

Quarterly NYMX Total Equity Data

06/2020$-1m
03/2020$1m
12/2019$3m
09/2019$6m
06/2019$8m
03/2019$10m
12/2018$7m
09/2018$4m
06/2018$4m
03/2018$-1m

Annual NYMX Total Equity Data

2019$3m
2018$7m
2017$-1m
2016$0m
2015$-2m
2014$-4m
2013$-6m
2012$-7m
2011$-5m
2010$-2m